Photo from Gilles Robinson/X
Dec 22, 2023, 14:14
Giles Robinson: We’re enrolling infants and young children with medulloblastoma on SJiMB21
Giles Robinson, Neuro-Oncology Division Director at the St. Jude Children’s Research Hospital, shared on X/Twitter:
“Medulloblastoma is the most common malignant childhood brain tumor. We’re enrolling infants and young children with medulloblastoma on SJiMB21, a trial that tailors treatment based on the tumor’s molecular group, subgroup and clinical risk.”
For more details, click here.
Source: Giles Robinson/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19